Metabolic-Fit / 100
LumiMeds review
A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, both prices are 'From' starting prices, and no content addresses postpartum or PCOS.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
LumiMeds at a glance
- Semaglutide
- From $99/mo
- Tirzepatide
- From $183/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored LumiMeds
Every factor comes from LumiMeds's own published pricing, disclosures and oversight, and the six combine into the 49/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.lumimeds.com
$99 for semaglutide and $183 for tirzepatide as starting prices across all fifty states — floors rather than guaranteed rates at a working dose. LumiMeds also holds FDA warning letter 716510, issued September 2025, which this review discloses rather than omits.
What to expect when you sign up
We walked LumiMeds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage lists 'From $X/month' starting prices for semaglutide, tirzepatide, and NAD+ directly, before any intake
- 2A BMI/weight-loss projection tool runs on the homepage using self-reported patient outcome data, not a clinical guarantee
- 3A named Medical Director (Dr. Teresa Walsh, M.D.) is credited, stated as 'Licensed in all 50 states'
- 4States 'No membership required' on every plan tile
What we noticed
- A named, credentialed Medical Director with explicit all-50-state licensure is a stronger trust signal than most long-tail providers in this round
- 'From $X/month' framing means the exact price at a working dose isn't guaranteed by the homepage number alone
- HSA/FSA accepted, and Klarna financing is offered on select plans
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 | Starting priceListed as 'From $99/month' — no membership required; exact price scales with dose. |
| Compounded tirzepatide | $183 | Starting priceListed as 'From $183/month' — no membership required; exact price scales with dose. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what LumiMeds's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Named Medical Director (Dr. Teresa Walsh, M.D.) stated as licensed in all 50 states
- No membership required on any plan
- HSA/FSA accepted, plus Klarna financing on select plans
- Also offers NAD+ injectable therapy on the same platform
The caveats
- FDA warning letter (#716510, issued September 9, 2025) cites Lumimeds for describing its compounded semaglutide/tirzepatide as equivalent to FDA-approved brand medication — compounded drugs are not FDA-approved, and the letter found the comparison misleading
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- Both prices are framed as 'From' — the exact cost at a working dose isn't guaranteed by the homepage figure
- No named compounding pharmacy found on the pages checked
- No brand-name (FDA-approved) option and no oral form
LumiMeds for mothers: our verdict
A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, both prices are 'From' starting prices, and no content addresses postpartum or PCOS. It runs about $99/month — toward the affordable end of what we track.
We weigh LumiMeds the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What LumiMeds costs, in full
- Compounded semaglutide — Starting price: $99/mo
- Compounded tirzepatide — Starting price: $183/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
LumiMeds says the price covers the provider visit, the medication, shipping and coaching. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications LumiMeds prescribes
LumiMeds prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where LumiMeds fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
LumiMeds is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a named, all-50-state-licensed Medical Director behind the program and are comfortable confirming the real working-dose price at intake.
Alternatives to LumiMeds
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing LumiMeds
Head-to-head & alternatives
LumiMeds, answered
- How much does LumiMeds cost?
- At last review, LumiMeds's lowest ongoing compounded rate was about $99 a month — From $99/mo for semaglutide, From $183/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is LumiMeds safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. LumiMeds is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does LumiMeds offer both semaglutide and tirzepatide?
- Yes — LumiMeds offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does LumiMeds rank for mothers?
- LumiMeds scores 49/100 on our Metabolic-Fit Score and sits at #107. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect LumiMeds's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.